ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2026
Chemotherapy-free regimen: Real-world efficacy and safety of anlotinib plus PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer.
Haiyang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.